Galderma's "Scratch Resistance" Campaign Aims to Address the Emotional and Physical Burdens of Atopic Dermatitis
SHERIDAN, WYOMING – May 9, 2025 – Galderma, a global leader in dermatology, has launched its highly anticipated "Scratch Resistance" campaign to help those living with atopic dermatitis (eczema). This new initiative highlights not only the physical burden of relentless itching but also the emotional toll it takes on individuals. The campaign focuses on encouraging patients to seek treatment with NEMLUVIO® (nemolizumab-ilto), a breakthrough treatment for atopic dermatitis that targets the root causes of itching and inflammation.